Insider Transactions in Q2 2025 at Intuitive Surgical Inc (ISRG)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2025
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
674
-0.29%
|
$354,524
$526.15 P/Share
|
|
Jun 10
2025
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,358
+0.58%
|
-
|
|
Jun 06
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
216
-19.23%
|
$121,608
$563.11 P/Share
|
|
Jun 05
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
215
-16.07%
|
$120,400
$560.7 P/Share
|
|
Jun 04
2025
|
David J. Rosa President |
SELL
Bona fide gift
|
Direct |
851
-0.37%
|
-
|
|
Jun 04
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
215
-13.84%
|
$118,680
$552.07 P/Share
|
|
Jun 03
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
215
-12.16%
|
$118,250
$550.68 P/Share
|
|
Jun 02
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
215
-10.84%
|
$118,035
$549.06 P/Share
|
|
May 16
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
20
-1.0%
|
$11,260
$563.81 P/Share
|
|
May 15
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
22
-1.09%
|
$12,320
$560.0 P/Share
|
|
May 14
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
22
-1.07%
|
$12,386
$563.0 P/Share
|
|
May 13
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
22
-1.06%
|
$12,342
$561.67 P/Share
|
|
May 12
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
22
-1.05%
|
$12,122
$551.97 P/Share
|
|
May 02
2025
|
Jamie Samath |
SELL
Open market or private sale
|
Direct |
915
-11.33%
|
$482,205
$527.95 P/Share
|
|
May 02
2025
|
Jamie Samath |
BUY
Exercise of conversion of derivative security
|
Direct |
915
+2.87%
|
$236,070
$258.32 P/Share
|
|
May 01
2025
|
Jami K Nachtsheim Director |
SELL
Open market or private sale
|
Direct |
2,400
-27.36%
|
$1,248,000
$520.0 P/Share
|
|
May 01
2025
|
Jami K Nachtsheim Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,400
+21.48%
|
$216,000
$90.49 P/Share
|
|
Apr 30
2025
|
Amy L Ladd Director |
SELL
Open market or private sale
|
Direct |
8,776
-55.12%
|
$4,431,880
$505.55 P/Share
|
|
Apr 30
2025
|
Amy L Ladd Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,776
+35.5%
|
$2,044,808
$233.6 P/Share
|
|
Apr 29
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
188
-3.47%
|
$96,256
$512.9 P/Share
|
|
Apr 29
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
188
+3.36%
|
$39,104
$208.9 P/Share
|
|
Apr 28
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
188
-3.47%
|
$96,820
$515.91 P/Share
|
|
Apr 28
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
188
+3.36%
|
$54,520
$290.33 P/Share
|
|
Apr 25
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
614
-2.85%
|
$314,982
$513.18 P/Share
|
|
Apr 25
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
614
+2.77%
|
$158,412
$258.32 P/Share
|
|
Apr 25
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-91.89%
|
$2,052,000
$513.18 P/Share
|
|
Apr 25
2025
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+47.89%
|
$968,000
$242.34 P/Share
|
|
Apr 25
2025
|
Gary Loeb EVP & Chief Legal and Complian |
SELL
Open market or private sale
|
Direct |
1,700
-43.09%
|
$872,100
$513.18 P/Share
|
|
Apr 25
2025
|
Jami K Nachtsheim Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+10.39%
|
-
|
|
Apr 25
2025
|
Lewis Chew Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+48.55%
|
-
|
|
Apr 25
2025
|
Amal M Johnson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+5.37%
|
-
|
|
Apr 25
2025
|
Monica P Reed Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+23.96%
|
-
|
|
Apr 25
2025
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,043
+3.69%
|
-
|
|
Apr 25
2025
|
Amy L Ladd Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+34.39%
|
-
|
|
Apr 25
2025
|
Sreelakshmi Kolli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+43.02%
|
-
|
|
Apr 25
2025
|
Keith R Leonard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+23.96%
|
-
|
|
Apr 25
2025
|
Mark J Rubash Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+4.22%
|
-
|
|
Apr 25
2025
|
Joseph C Beery Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+19.2%
|
-
|